Richard W. Vilter
University of Cincinnati
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Richard W. Vilter.
Vitamins and Hormones Series | 1964
Richard W. Vilter
Publisher Summary Isoniazid and other hydrazides can induce vitamin B6 deficiency manifestations, especially convulsions and neuritis. These can be prevented by vitamin B6 administration. The probable mechanism responsible is the formation of a pyridoxal-isonicotinic acid hydrazide (INH) hydrazone. Vitamin B6 may be excreted in this combination or the hydrazone may bind pyridoxal phosphate, preventing it from combining with certain vitamin B6-dependent apoenzymes. Other apoenzymes may have a greater affinity for vitamin B6 phosphate than INH and may not be inhibited at all. Inhibition of pyridoxal kinase may be a very important effect inducing vitamin B6 deficiency. Though very large doses of vitamin B6 may inhibit the effectiveness of INH against the tubercle bacillus, doses of vitamin B6 used in clinical medicine do not seem to interfere with the antituberculous effect of INH in vivo and in vitro.
Archives of Biochemistry and Biophysics | 1951
Helen S. Glazer; Betty Fichter; John F. Mueller; Richard W. Vilter
There is evidence in the literature that the conversion of tryptophan to N1-methylnicotinamide may require pyridoxine (1,2,3). Holt (4) has suggested that a reduction in the amount of N’-methylnicotinamide excreted after a test dose of tryptophan may be used as a test for pyridoxine deficiency. Other evidence has been reported (5,6), however, that pyridoxine is not a factor of primary importance in the conversion and that the apparent relationship between pyridoxine deficiency and poor conversion of tryptophan to N’-methylnicotinamide is due to severe caloric restriction (6) or protein imbalance (7,8). Heimberg, Rosen, Leder, and Perlzweig (9) have shown that the protein level of the diet is of primary importance to the amount of N’-methylnicotinamide excreted, after test doses of tryptophan; the higher the protein level the lower the amount of N1-methylnicotinamide. They found no evidence to support a primary need for pyridoxine in this conversion, though at a 10% casein level, pyridoxine deprivation induced a reduction in the amount of N’-methylnicotinamide excreted. Using desoxypyridoxine, a pyridoxine antagonist, we have produced what appears to be pyridoxine deficiency in human beings (10). Seborrhea-like dermatitis and mucous membrane lesions are induced which respond to pyridoxine but not to other members of the vitamin B com-
Annals of Internal Medicine | 1940
Tom D. Spies; William B. Bean; Richard W. Vilter
Excerpt From our studies of a large series of persons with mixed vitamin deficiency, we reported recently1, 2, 3that the diagnostic manifestations of pellagra, beriberi, riboflavin deficiency, vita...
Annals of Internal Medicine | 1939
William B. Bean; Richard W. Vilter; Tom D. Spies
Excerpt It is a well known fact that therapeutic doses of roentgen-ray frequently give rise to a train of symptoms characterized by nausea, vomiting, abdominal cramps, headache and general malaise....
Annals of Internal Medicine | 1973
Robert S. Daniels; Richard W. Vilter
Excerpt As our medical schools were beginning to recover from the manpower drain caused by World War II, the National Institutes of Health, supported by Congressional action, began to award funds f...
Journal of Laboratory and Clinical Medicine | 1953
Richard W. Vilter; John F. Mueller; Helen S. Glazer; Thomas Jarrold; Joseph Abraham; Carl V. Thompson; Virginia R. Hawkins
Blood | 1950
Richard W. Vilter; Daniel L. Horrigan; John F. Mueller; Thomas Jarrold; Carl F. Vilter; Virginia R. Hawkins; Arthur Seaman
Journal of Clinical Investigation | 1950
John F. Mueller; Richard W. Vilter
JAMA | 1939
Tom D. Spies; Richard W. Vilter; William F. Ashe
Blood | 1960
Richard W. Vilter; Thomas Jarrold; John J. Will; John F. Mueller; Ben Friedman; Virginia R. Hawkins